HPPD variants and methods of use

US12305181B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12305181-B2
Application numberUS-201916537801-A
CountryUS
Kind codeB2
Filing dateAug 12, 2019
Priority dateMar 11, 2014
Publication dateMay 20, 2025
Grant dateMay 20, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In the present invention, HPPD enzymes and plants containing them showing a full tolerance against several classes of HPPD-inhibitors are described. A set of HPPD enzymes have been designed which have either no or only a significantly reduced affinity to HPPD inhibitors and, at the same time, the rate of dissociation of the HPPD inhibitors of the enzyme is increased to such an extent that the HPPD inhibitors no longer act as slow-binding or slow, tight-binding inhibitors but, instead of this, have become fully reversible inhibitors. In particular, isolated polynucleotides encoding HPPD inhibitor tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant nucleic acid molecule encoding a 4-hydroxyphenylpyruvate dioxygenase (HPPD) protein comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 1, wherein said amino acid sequence comprises a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1 and a tyrosine at the amino acid position corresponding to amino acid position 336 of SEQ ID NO: 1, and wherein said HPPD protein is tolerant to an HPPD inhibitor herbicide, wherein the amino acid sequence further comprises (i) an alanine at the amino acid position corresponding to amino acid position 339 of SEQ ID NO:1; or (ii) a glutamic acid, or glutamine at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1. 2. The recombinant nucleic acid molecule of claim 1 , wherein said HPPD amino acid sequence further comprises: (i) a proline or leucine at the amino acid position corresponding to amino acid position 215 of SEQ ID NO:1. 3. The recombinant nucleic acid molecule of claim 1 , wherein its nucleotide sequence is a synthetic sequence that has been designed for expression in a plant. 4. The recombinant nucleic acid molecule of claim 1 , wherein its nucleotide sequence is operably linked to a promoter capable of directing expression of the nucleotide sequence in a plant cell. 5. A host cell comprising the recombinant nucleic acid molecule of claim 1 . 6. The host cell of claim 5 that is a bacterial host cell. 7. The host cell of claim 5 that is a plant cell. 8. A transgenic plant comprising the recombinant nucleic acid molecule of claim 1 . 9. The plant of claim 8 , wherein said plant is selected from the group consisting of maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugar beet, sugarcane, tobacco, barley, and oilseed rape. 10. A transgenic seed comprising the recombinant nucleic acid molecule of claim 1 . 11. A method of controlling weeds in a field comprising planting the plant of claim 8 in a field and applying to said field an effective concentration of an HPPD inhibitor herbicide. 12. The method of claim 11 , wherein said HPPD inhibitor herbicide is selected from the group consisting of N-(1,2,5-oxadiazol-3-yl)benzamides; N-(tetrazol-4-yl)- or N-(triazol-3-yl)-arylcarboxamides, N-(1,3,4-oxadiazol-2-yl)benzamides, N-(tetrazol-5-yl)- or N-(triazol-3-yl)arylcarboxamides, pyridazinone derivatives, substituted 1,2,5-oxadiazoles, oxoprazin derivatives, triketones, isoxazoles, and pyrazolinates. 13. The method of claim 12 , wherein said HPPD inhibitor herbicide is selected from the group consisting of 2-chloro-3-ethoxy-4-(methylsulfonyl)-N-(1-methyl-1H-tetrazol-5-yl)benzamide and 2-Chloro-3-(methoxymethyl)-4-(methylsulfonyl)-N-(1-methyl-1H-tetrazol-5-yl)benzamide, 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide, 2-chloro-3-ethoxy-4-(methylsulfonyl)-N-(1-methyl-1H-tetrazol-5-yl)benzamide, 4-(difluoromethyl)-2-methoxy-3-(methylsulfonyl)-N-(1-methyl-1H-tetrazol-5-yl)benzamide, 2-chloro-3-(methylsulfanyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide, 2-(methoxymethyl)-3-(methylsulfinyl)-N-(1-methyl-1H-tetrazol-5-yl)-4-(trifluoromethyl)benzamide, tembotrione, sulcotrione, mesotrione, isoxaflutole, pyrasulfotole, and topramezone.

Assignees

Inventors

Classifications

  • Catechol 1,2-dioxygenase (1.13.11.1) · CPC title

  • having rings with four or more nitrogen atoms as the only ring hetero atoms · CPC title

  • C12N9/0069Primary

    acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13) · CPC title

  • 4-Hydroxyphenylpyruvate dioxygenase (1.13.11.27) · CPC title

  • for herbicide resistance · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12305181B2 cover?
In the present invention, HPPD enzymes and plants containing them showing a full tolerance against several classes of HPPD-inhibitors are described. A set of HPPD enzymes have been designed which have either no or only a significantly reduced affinity to HPPD inhibitors and, at the same time, the rate of dissociation of the HPPD inhibitors of the enzyme is increased to such an extent that…
Who is the assignee on this patent?
BASF Agricultural Solutions Seed US LLC, Basf Agricultural Solutions Us Llc
What technology area does this patent fall under?
Primary CPC classification C12N9/0069. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).